-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[Pharmaceutical Network Industry News] With the stricter supervision of the pharmaceutical industry, cases of pharmacies being punished frequently occur
.
For example, recently, the State Food and Drug Administration announced five typical cases of special drug safety rectification, and a chain pharmacy was fined 1.
25 million yuan for illegal drug purchases and other issues
.
The announcement shows that in October 2021, the Liaoning Provincial Food and Drug Administration found that a large pharmacy chain Co.
, Ltd.
in Shenyang had not purchased the "Jingling Oral Liquid" drug from a drug marketing license holder or an enterprise qualified for drug production and operation.
; Fabricating purchase records in the computer system, failing to ask for invoices from the supplier when purchasing drugs, and untraceable information on drug procurement, storage and distribution, etc.
; the legal representative Zhao Moulin has never actually worked in the company and failed to perform relevant management The three major violations of duty were imposed by the Liaoning Provincial Food and Drug Administration with a fine of 1.
25 million yuan, and the company's legal representative was banned from engaging in drug production and business activities for life
.
It is worth noting that, after sorting out, it is found that there are actually not a few pharmacies that have been fined for illegally purchasing drugs recently
.
On April 13, the Yunnan Food and Drug Administration announced a number of typical cases.
A chain pharmacy was fined 1 million yuan for failing to establish true and complete purchase and sales records and for failing to achieve full control of related drugs
.
On March 22, it was reported that a chain of pharmacies in Guangzhou had been queuing up to buy prepared medicines from medical institutions and sold them online.
It was suspected of illegally buying and selling medicines and was fined nearly 600,000 yuan by the regulatory authorities.
On March 2, it was reported that, A pharmacy in Jinniu District, Chengdu purchased atorvastatin, rosuvastatin and other drugs from personal channels, and was filed by the regulatory authorities, and the illegal gains were confiscated and fined 100,000 yuan
.
In addition to the above-mentioned companies that were fined for illegally purchasing medicines, the Food and Drug Administration in many places recently also notified a large number of pharmacies that were fined for selling inferior medicines and not complying with relevant regulations
.
For example, on April 19, the Shushan District Market Supervision Bureau of Hefei City found during an on-site inspection that medical masks, alcohol and other epidemic prevention supplies sold by a chain pharmacy Co.
, Ltd.
were not clearly priced, and were ordered to confiscate illegal gains and fined 5,000 yuan according to law.
penalty
.
When the Hubei Provincial Market Supervision Bureau released some typical cases of illegal advertisements investigated and dealt with by the province's market supervision system in the first quarter of 2022, a pharmacy was also fined 200,000 yuan for publishing an illegal advertisement entitled "How to eat Ejiao in summer"
.
Industry analysts believe that, in fact, since the release of the new Drug Administration Law, the cost of pharmacy violations has been increasing, and cases of fines of 100,000 yuan or more by regulatory authorities have long been common
.
In the future, with the further tightening of supervision, if there are business violations in the pharmacy industry, it will be inevitable to receive huge fines
.
It is understood that the Drug Supervision Department of the State Food and Drug Administration has recently held a special inspection work conference on drug distribution and use
.
The meeting requested that in 2022, the supervision of drug operation should focus on 6 tasks, including "strict investigation and severe punishment, and comprehensive implementation of special inspection requirements for operation and use"
.
In addition, many provinces across the country have also successively released the 2022 drug business inspection work plan
.
Under this background, the pharmacy industry can gain long-term competitiveness only by standardizing its operation and developing towards informatization and specialization
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
.
For example, recently, the State Food and Drug Administration announced five typical cases of special drug safety rectification, and a chain pharmacy was fined 1.
25 million yuan for illegal drug purchases and other issues
.
The announcement shows that in October 2021, the Liaoning Provincial Food and Drug Administration found that a large pharmacy chain Co.
, Ltd.
in Shenyang had not purchased the "Jingling Oral Liquid" drug from a drug marketing license holder or an enterprise qualified for drug production and operation.
; Fabricating purchase records in the computer system, failing to ask for invoices from the supplier when purchasing drugs, and untraceable information on drug procurement, storage and distribution, etc.
; the legal representative Zhao Moulin has never actually worked in the company and failed to perform relevant management The three major violations of duty were imposed by the Liaoning Provincial Food and Drug Administration with a fine of 1.
25 million yuan, and the company's legal representative was banned from engaging in drug production and business activities for life
.
It is worth noting that, after sorting out, it is found that there are actually not a few pharmacies that have been fined for illegally purchasing drugs recently
.
On April 13, the Yunnan Food and Drug Administration announced a number of typical cases.
A chain pharmacy was fined 1 million yuan for failing to establish true and complete purchase and sales records and for failing to achieve full control of related drugs
.
On March 22, it was reported that a chain of pharmacies in Guangzhou had been queuing up to buy prepared medicines from medical institutions and sold them online.
It was suspected of illegally buying and selling medicines and was fined nearly 600,000 yuan by the regulatory authorities.
On March 2, it was reported that, A pharmacy in Jinniu District, Chengdu purchased atorvastatin, rosuvastatin and other drugs from personal channels, and was filed by the regulatory authorities, and the illegal gains were confiscated and fined 100,000 yuan
.
In addition to the above-mentioned companies that were fined for illegally purchasing medicines, the Food and Drug Administration in many places recently also notified a large number of pharmacies that were fined for selling inferior medicines and not complying with relevant regulations
.
For example, on April 19, the Shushan District Market Supervision Bureau of Hefei City found during an on-site inspection that medical masks, alcohol and other epidemic prevention supplies sold by a chain pharmacy Co.
, Ltd.
were not clearly priced, and were ordered to confiscate illegal gains and fined 5,000 yuan according to law.
penalty
.
When the Hubei Provincial Market Supervision Bureau released some typical cases of illegal advertisements investigated and dealt with by the province's market supervision system in the first quarter of 2022, a pharmacy was also fined 200,000 yuan for publishing an illegal advertisement entitled "How to eat Ejiao in summer"
.
Industry analysts believe that, in fact, since the release of the new Drug Administration Law, the cost of pharmacy violations has been increasing, and cases of fines of 100,000 yuan or more by regulatory authorities have long been common
.
In the future, with the further tightening of supervision, if there are business violations in the pharmacy industry, it will be inevitable to receive huge fines
.
It is understood that the Drug Supervision Department of the State Food and Drug Administration has recently held a special inspection work conference on drug distribution and use
.
The meeting requested that in 2022, the supervision of drug operation should focus on 6 tasks, including "strict investigation and severe punishment, and comprehensive implementation of special inspection requirements for operation and use"
.
In addition, many provinces across the country have also successively released the 2022 drug business inspection work plan
.
Under this background, the pharmacy industry can gain long-term competitiveness only by standardizing its operation and developing towards informatization and specialization
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
